Antiinflammatory effects of orientin-2″-O-galactopyranoside on lipopolysaccharide-stimulated microglia

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 8, 2014, Pages 1282-1294

  Zhou, Xiang ^a   Gan, Ping ^a   Hao, Lili ^a   Tao, Li ^a   Jia, Jia ^a   Gao, Bo ^a   Liu, Jiang Yun ^a   Zheng, Long Tai ^a   Zhen, Xuechu ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Inflammation; Lipopolysaccharide; Microglia; Neuroprotection; Orientin 2 O galactopyranoside

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORIENTIN 2'' O GALACTOPYRANOSIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; FLAVONE DERIVATIVE; GALACTOSIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NOS2 PROTEIN, MOUSE; ORIENTIN-2''-O-GALACTOPYRANOSIDE; PTGS2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; HERB; MICROGLIA; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TROLLIUS CHINENSIS; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; GENETICS; METABOLISM; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONES; GALACTOSIDES; HEME OXYGENASE-1; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906773455     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00083     Document Type: Article

References (61)

1. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann. N. Y. Acad. Sci., 1035, 104-116 (2004).
2. Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J., 26, 3103-3117 (2012).
3. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 8, 57-69 (2007).
4. Park SY, Jin ML, Kim YH, Kim Y, Lee SJ. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-kappaB, JNK, and p38 MAPK signaling pathways in amyloid beta-stimulated microglia. Int. Immunopharmacol., 14, 13-20 (2012).
5. Santos RM, Lourenco CF, Ledo A, Barbosa RM, Laranjinha J. Nitric oxide inactivation mechanisms in the brain: role in bioenergetics and neurodegeneration. Int. J. Cell Biol., 2012, 1-13 (2012).
6. Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol., 7, 42-59 (2012).
7. Oka A, Takashima S. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. Neuroreport, 8, 1161-1164 (1997).
8. Thameen Dheen S, Kaur C, Ling E-A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem., 14, 1189-1197 (2007).
9. Cai SQ, Wang R, Yang X, Shang M, Ma C, Shoyama Y. Antiviral flavonoid-type C-glycosides from the flowers of Trollius chinensis. Chem. Biodivers., 3, 343-348 (2006).
10. Wang RF, Yang XW, Ma CM, Liu HY, Shang MY, Zhang QY, Cai SQ, Park JH. Trollioside, a new compound from the flowers of Trollius chinensis. J. Asian Nat. Prod. Res., 6, 139-144 (2004).
11. Liu JY, Li SY, Feng JY, Sun Y, Cai JN, Sun XF, Yang SL. Flavone C-glycosides from the flowers of Trollius chinensis and their anti-complementary activity. J. Asian Nat. Prod. Res., 15, 325-331 (2013).
12. Perveen S, El-Shafae AM, Al-Taweel A, Fawzy GA, Malik A, Afza N, Latif M, Iqbal L. Antioxidant and urease inhibitory C-glycosylflavonoids from Celtis africana. J. Asian Nat. Prod. Res., 13, 799-804 (2011).
13. Becker H, Scher JM, Speakman JB, Zapp J. Bioactivity guided isolation of antimicrobial compounds from Lythrum salicaria. Fitoterapia, 76, 580-584 (2005).
14. Lee CY, Chien YS, Chiu TH, Huang WW, Lu CC, Chiang JH, Yang JS. Apoptosis triggered by vitexin in U937 human leukemia cells via a mitochondrial signaling pathway. Oncol. Rep., 28, 1883-1888 (2012).
15. Fu XC, Wang X, Zheng H, Ma LP. Protective effects of orientin on myocardial ischemia and hypoxia in animal models. Nan Fang Yi Ke Da Xue Xue Bao, 27, 1173-1175 (2007).
16. Yang L, Yang ZM, Zhang N, Tian Z, Liu SB, Zhao MG. Neuroprotective effects of vitexin by inhibition of NMDA receptors in primary cultures of mouse cerebral cortical neurons. Mol. Cell. Biochem., 386, 251-258 (2014).
17. Hassan NF, Rifat S, Campbell DE, McCawley LJ, Douglas SD. Isolation and flow cytometric characterization of newborn mouse brain-derived microglia maintained in vitro. J. Leukoc. Biol., 50, 86-92 (1991).
18. Lee S, Suk K. Heme oxygenase-1 mediates cytoprotective effects of immunostimulation in microglia. Biochem. Pharmacol., 74, 723-729 (2007).
19. Hwang J, Zheng LT, Ock J, Lee MG, Suk K. Anti-inflammatory effects of m-chlorophenylpiperazine in brain glia cells. Int. Immunopharmacol., 8, 1686-1694 (2008).
20. Zheng LT, Ryu GM, Kwon BM, Lee WH, Suk K. Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity. Eur. J. Pharmacol., 588, 106-113 (2008).
21. Jung WK, Ahn YW, Lee SH, Choi YH, Kim SK, Yea SS, Choi I, Park SG, Seo SK, Lee SW, Choi IW. Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways. Food Chem. Toxicol., 47, 410-417 (2009).
22. Kaltschmidt B, Kaltschmidt C. NF-kappaB in the nervous system. Cold Spring Harb. Perspect. Biol., 1, a001271 (2009).
23. Lee TY, Lee KC, Chen SY, Chang HH. 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-alpha and NF-kappaB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochem. Biophys. Res. Commun., 382, 134-139 (2009).
24. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol., 58, 233-247 (1999).
25. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog. Neurobiol., 57, 563-581 (1999).
26. McGeer EG, McGeer PL. The role of anti-inflammatory agents in Parkinson's disease. CNS Drugs, 21, 789-797 (2007).
27. Schroeter ML, Muller S, Lindenau J, Wiesner B, Hanisch UK, Wolf G, Blasig IE. Astrocytes induce manganese superoxide dismutase in brain capillary endothelial cells. Neuroreport, 12, 2513-2517 (2001).
28. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. The Scientific World Journal, 2012, 1-15 (2012).
29. Hoarau J-J, Krejbich-Trotot P, Jaffar-Bandjee M-C, Das T, Thon-Hon G-V, Kumar S, Neal JW, Gasque P. Activation and control of CNS innate immune responses in health and diseases: a balancing act finely tuned by neuroimmune regulators (NIReg). CNS Neurol. Disord. Drug Targets, 10, 25-43 (2011).
30. Li YL, Ma SC, Yang YT, Ye SM, But PP. Antiviral activities of flavonoids and organic acid from Trollius chinensis BUNGE. J. Ethnopharmacol., 79, 365-368 (2002).
31. Matsuda H, Morikawa T, Ando S, Toguchida I, Yoshikawa M. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorg. Med. Chem., 11, 1995-2000 (2003).
32. González-Ramos R, Defrere S, Devoto L. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil. Steril., 98, 520-528 (2012).
33. Iwai K. Diverse ubiquitin signaling in NF-kappaB activation. Trends Cell Biol., 22, 355-364 (2012).
34. Kanarek N, Ben-Neriah Y. Regulation of NF-kappaB by ubiquitination and degradation of the IkappaBs. Immunol. Rev., 246, 77-94 (2012).
35. Han S, Lee JH, Kim C, Nam D, Chung WS, Lee SG, Ahn KS, Cho SK, Cho M, Ahn KS. Capillarisin inhibits iNOS, COX-2 expression, and proinflammatory cytokines in LPS-induced RAW 264.7 macrophages via the suppression of ERK, JNK, and NF-kappaB activation. Immunopharmacol. Immunotoxicol., 35, 34-42 (2013).
36. Xie C, Kang J, Li Z, Schauss AG, Badger TM, Nagarajan S, Wu T, Wu X. The acai flavonoid velutin is a potent anti-inflammatory agent: blockade of LPS-mediated TNF-alpha and IL-6 production through inhibiting NF-kappaB activation and MAPK pathway. J. Nutr. Biochem., 23, 1184-1191 (2012).
37. Cui Y, Wu J, Jung S-C, Park D-B, Maeng Y-H, Hong JY, Kim S-J, Lee S-R, Kim S-J, Kim SJ, Eun S-Y. Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation. Biol. Pharm. Bull., 33, 1814-1821 (2010).
38. Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia, 40, 175-183 (2002).
39. Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci., 18, 1633-1641 (1998).
40. Kan H, Xie Z, Finkel MS. TNF-alpha enhances cardiac myocyte NO production through MAP kinase-mediated NF-kappaB activation. Am. J. Physiol., 277, H1641-H1646 (1999).
41. Jiang B, Brecher P, Cohen RA. Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler. Thromb. Vasc. Biol., 21, 1915-1920 (2001).
42. Doi M, Shichiri M, Katsuyama K, Marumo F, Hirata Y. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells. Hypertens. Res., 23, 659-667 (2000).
43. Nishanth RP, Jyotsna RG, Schlager JJ, Hussain SM, Reddanna P. Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFkappaB signaling pathway. Nanotoxicology, 5, 502-516 (2011).
44. Kim SU, Park YH, Min JS, Sun HN, Han YH, Hua JM, Lee TH, Lee SR, Chang KT, Kang SW, Kim JM, Yu DY, Lee SH, Lee DS. Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-kappaB-mediated iNOS induction and microglial activation. J. Neuroimmunol., 259, 26-36 (2013).
45. Kim M, Li YX, Dewapriya P, Ryu B, Kim SK. Floridoside suppresses pro-inflammatory responses by blocking MAPK signaling in activated microglia. BMB Rep., 46, 398-403 (2013).
46. Jazwa A, Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr. Drug Targets, 11, 1517-1531 (2010).
47. Hsu HY, Chu LC, Hua KF, Chao LK. Heme oxygenase-1 mediates the anti-inflammatory effect of curcumin within LPS-stimulated human monocytes. J. Cell. Physiol., 215, 603-612 (2008).
48. Lee IS, Lim J, Gal J, Kang JC, Kim HJ, Kang BY, Choi HJ. Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells. Neurochem. Int., 58, 153-160 (2011).
49. Park JS, Jung JS, Jeong YH, Hyun JW, Le TK, Kim DH, Choi EC, Kim HS. Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression. J. Neurochem., 119, 909-919 (2011).
50. Chen HG, Xie KL, Han HZ, Wang WN, Liu DQ, Wang GL, Yu YH. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW264.7 macrophages. Int. J. Surg., 11, 1060-1066 (2013).
51. Shinkai Y, Yamanaka I, Duong HH, Quynh NT, Kanaho Y, Kumagai Y. Garcinia vilersiana bark extract activates the Nrf2/HO-1 signaling pathway in RAW264.7 cells. J. Toxicol. Sci., 38, 875-878 (2013).
52. Shih RH, Cheng SE, Hsiao LD, Kou YR, Yang CM. Cigarette smoke extract upregulates heme oxygenase-1 via PKC/NADPH oxidase/ROS/PDGFR/PI3K/Akt pathway in mouse brain endothelial cells. J. Neuroinflammation, 8, 104-117 (2011).
53. 2-induced oxidative stress and apoptosis through upregulation of HO-1 expression via activation of the PI3K/Akt/Nrf2 pathway. Phytother. Res., PTR, 27, 1810-1818 (2013).
54. Jeong YH, Jung JS, Le TK, Kim DH, Kim HS. Lancemaside A inhibits microglial activation via modulation of JNK signaling pathway. Biochem. Biophys. Res. Commun., 431, 369-375 (2013).
55. Hartsfield CL, Alam J, Choi AM. Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate. FASEB J., 12, 1675-1682 (1998).
56. McGeer PL, McGeer EG. Glial reactions in Parkinson's disease. Mov. Disord., 23, 474-483 (2008).
57. Makino T, Shimizu R, Kanemaru M, Suzuki Y, Moriwaki M, Mizukami H. Enzymatically modified isoquercitrin, alpha-oligoglucosyl quercetin 3-O-glucoside, is absorbed more easily than other quercetin glycosides or aglycone after oral administration in rats. Biol. Pharm. Bull., 32, 2034-2040 (2009).
58. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med., 36, 592-604 (2004).
59. Spencer B, Marr RA, Gindi R, Potkar R, Michael S, Adame A, Rockenstein E, Verma IM, Masliah E. Peripheral delivery of a CNS targeted, metallo-protease reduces abeta toxicity in a mouse model of Alzheimer's disease. PLoS ONE, 6, e16575 (2011).
60. Ohtsuki S, Yamaguchi H, Kang YS, Hori S, Terasaki T. Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson's disease. Biol. Pharm. Bull., 33, 1250-1252 (2010).
61. Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, Shah GN, Price TO, Fleegal-Demotta MA, Butterfiled DA, Banks WA. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav. Immun., 23, 507-517 (2009).